Lifecome Biochemistry Co Ltd (002868) — Capital Reinvestment Ratio
Lifecome Biochemistry Co Ltd (002868) has a Capital Reinvestment Ratio of 0.23x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥13.24 Million) in capital expenditures (CN¥3.02 Million). See debt-free asset ratio of Lifecome Biochemistry Co Ltd to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Lifecome Biochemistry Co Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks Lifecome Biochemistry Co Ltd's Capital Reinvestment Ratio across 11 annual periods. Check cash flow reinvestment rate of Lifecome Biochemistry Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Lifecome Biochemistry Co Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for Lifecome Biochemistry Co Ltd from 2012 to 2024. For live market cap and broader valuation context, see Lifecome Biochemistry Co Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.88x | CN¥141.41 Million | CN¥125.06 Million | ▼ -91.3% |
| 2021 | 10.16x | CN¥35.17 Million | CN¥357.17 Million | ▲ +263.0% |
| 2020 | 2.80x | CN¥90.72 Million | CN¥253.79 Million | ▲ +65.0% |
| 2019 | 1.70x | CN¥74.09 Million | CN¥125.60 Million | ▲ +190.0% |
| 2018 | 0.58x | CN¥83.70 Million | CN¥48.93 Million | ▲ +202.7% |
| 2017 | 0.19x | CN¥96.11 Million | CN¥18.56 Million | ▲ +76.5% |
| 2016 | 0.11x | CN¥135.41 Million | CN¥14.82 Million | ▼ -64.9% |
| 2015 | 0.31x | CN¥127.11 Million | CN¥39.65 Million | ▼ -20.6% |
| 2014 | 0.39x | CN¥62.76 Million | CN¥24.66 Million | ▼ -46.4% |
| 2013 | 0.73x | CN¥77.68 Million | CN¥57.00 Million | ▼ -9.2% |
| 2012 | 0.81x | CN¥60.92 Million | CN¥49.25 Million | — |